SECsense Logo

Neumora Therapeutics 8-K Report: Key Updates from February 13, 2025

$NMRA
Form 8-K
Filed on: 2025-02-13
Source
Neumora Therapeutics 8-K Report: Key Updates from February 13, 2025

Here are the key insights and information extracted from the provided section of the financial report:

  1. Company Information:
  • Name: Neumora Therapeutics, Inc.
  • Address: 490 Arsenal Way, Suite 200, Watertown, MA 02472
  • Phone: (857) 760-0900
  • CIK Identifier: 0001885522
  • IRS Employer Identification Number: 84-4367680
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: February 13, 2025
  • SEC File Number: 001-41802
  1. Stock Information:
  • Common Stock: Par value of $0.0001 per share
  • Trading Symbol: NMRA
  • Exchange: NASDAQ
  1. Reporting Context:
  • The reporting period covers February 13, 2025, indicating this is likely a current report detailing significant events or changes affecting the company.
  1. XML and XBRL Context:
  • This information is structured in XBRL format, which is used for financial reporting and facilitates the sharing and analysis of financial data.

Overall, this report is a current event filing (8-K) by Neumora Therapeutics, Inc., indicating that important, potentially market-sensitive information was disclosed on February 13, 2025.